Q1 Earnings Forecast for McKesson Issued By Leerink Partnrs

McKesson Co. (NYSE:MCK) – Analysts at Leerink Partnrs issued their Q1 2026 earnings per share (EPS) estimates for McKesson in a research note issued to investors on Wednesday, April 2nd. Leerink Partnrs analyst M. Cherny forecasts that the company will post earnings per share of $8.34 for the quarter. The consensus estimate for McKesson’s current full-year earnings is $32.77 per share. Leerink Partnrs also issued estimates for McKesson’s Q2 2026 earnings at $8.57 EPS, Q3 2026 earnings at $9.46 EPS, Q4 2026 earnings at $10.38 EPS and FY2026 earnings at $36.75 EPS.

MCK has been the subject of a number of other research reports. Morgan Stanley boosted their target price on McKesson from $642.00 to $745.00 and gave the stock an “overweight” rating in a research report on Wednesday. Evercore ISI boosted their price objective on McKesson from $650.00 to $675.00 and gave the stock an “outperform” rating in a report on Thursday, February 6th. Bank of America reduced their target price on shares of McKesson from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. StockNews.com downgraded shares of McKesson from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 14th. Finally, Citigroup cut their price objective on shares of McKesson from $713.00 to $677.00 and set a “buy” rating on the stock in a report on Friday, January 10th. Two investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $661.00.

McKesson Price Performance

MCK stock opened at $716.71 on Thursday. The company has a 50 day moving average price of $631.55 and a 200 day moving average price of $583.78. McKesson has a fifty-two week low of $464.42 and a fifty-two week high of $725.00. The stock has a market capitalization of $89.82 billion, a PE ratio of 32.82, a price-to-earnings-growth ratio of 1.29 and a beta of 0.49.

McKesson (NYSE:MCK) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $8.03 earnings per share for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a net margin of 0.82% and a negative return on equity of 181.26%.

McKesson Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, April 1st. Investors of record on Monday, March 3rd were issued a dividend of $0.71 per share. The ex-dividend date of this dividend was Monday, March 3rd. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.40%. McKesson’s payout ratio is 13.00%.

Insider Activity at McKesson

In other McKesson news, CEO Brian S. Tyler sold 8,961 shares of the business’s stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $600.66, for a total value of $5,382,514.26. Following the sale, the chief executive officer now owns 69,625 shares in the company, valued at approximately $41,820,952.50. The trade was a 11.40 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Leann B. Smith sold 188 shares of the company’s stock in a transaction that occurred on Wednesday, February 12th. The stock was sold at an average price of $609.59, for a total value of $114,602.92. Following the transaction, the executive vice president now directly owns 1,051 shares of the company’s stock, valued at approximately $640,679.09. This trade represents a 15.17 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 18,110 shares of company stock valued at $10,855,706. 0.11% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On McKesson

Several hedge funds and other institutional investors have recently added to or reduced their stakes in MCK. Versant Capital Management Inc increased its position in shares of McKesson by 75.7% in the first quarter. Versant Capital Management Inc now owns 592 shares of the company’s stock valued at $398,000 after acquiring an additional 255 shares during the last quarter. Central Pacific Bank Trust Division grew its stake in McKesson by 153.0% in the first quarter. Central Pacific Bank Trust Division now owns 2,535 shares of the company’s stock valued at $1,706,000 after purchasing an additional 1,533 shares in the last quarter. First Hawaiian Bank increased its position in shares of McKesson by 55.0% during the 1st quarter. First Hawaiian Bank now owns 5,580 shares of the company’s stock worth $3,755,000 after purchasing an additional 1,980 shares during the last quarter. MassMutual Private Wealth & Trust FSB raised its stake in shares of McKesson by 34.3% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 849 shares of the company’s stock worth $571,000 after purchasing an additional 217 shares in the last quarter. Finally, Avant Financial Advisors LLC acquired a new stake in shares of McKesson in the 4th quarter valued at approximately $578,000. 85.07% of the stock is currently owned by institutional investors and hedge funds.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.